Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0Y7EM
|
||||
| Former ID |
DIB007999
|
||||
| Drug Name |
Felbinac
|
||||
| Synonyms |
Felbinac); Felbinac, Takeda Chemical Industries Ltd; Seltouch, Takeda
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Arthritis [ICD9: 710-719; ICD10:M00-M25] | Approved | [1] | ||
| Company |
Takeda Pharmaceutical Co Ltd
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C14H12O2
|
||||
| Canonical SMILES |
C(=O)(Cc1ccc(c2ccccc2)cc1)O
|
||||
| CAS Number |
CAS 5728-52-9
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cyclooxygenase | Target Info | Modulator | [2], [1] | |
| References | |||||
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | ||||
| REF 2 | A review of the effects of fenbufen and a metabolite, biphenylacetic acid, on platelet biochemistry and function. Arzneimittelforschung. 1980;30(4A):702-7. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.